These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19274778)

  • 21. Differences in peptic ulcer between the East and the West.
    Leong RW
    Gastroenterol Clin North Am; 2009 Jun; 38(2):363-79. PubMed ID: 19446264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
    Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
    Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
    Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
    Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology and risk factors of gastroduodenal ulcer].
    Kreiss C; Blum AL
    Chirurg; 1996 Jan; 67(1):7-13. PubMed ID: 8851669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptic ulcer disease.
    Lanas A; Chan FKL
    Lancet; 2017 Aug; 390(10094):613-624. PubMed ID: 28242110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake.
    Charpignon C; Lesgourgues B; Pariente A; Nahon S; Pelaquier A; Gatineau-Sailliant G; Roucayrol AM; Courillon-Mallet A;
    Aliment Pharmacol Ther; 2013 Oct; 38(8):946-54. PubMed ID: 23981105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication].
    Ballesteros-Amozurrutia MA
    Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):41-9. PubMed ID: 11464621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication.
    Bobrzyński A; Beben P; Budzyński A; Bielański W; Plonka M; Konturek S
    Med Sci Monit; 2002 Aug; 8(8):CR554-7. PubMed ID: 12165741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs.
    Stolte M
    Lancet; 1998 Dec 19-26; 352(9145):2016; author reply 2017. PubMed ID: 9872269
    [No Abstract]   [Full Text] [Related]  

  • 31. Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: Multicenter follow-up study of peptic ulcers in Japan.
    Kanno T; Iijima K; Abe Y; Yagi M; Asonuma S; Ohyauchi M; Ito H; Koike T; Shimosegawa T
    Dig Endosc; 2016 Jul; 28(5):556-63. PubMed ID: 26866510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori and NSAID-induced ulcers.
    Savarino V; Vigneri S; Celle G
    Lancet; 1997 Nov; 350(9090):1556. PubMed ID: 9388434
    [No Abstract]   [Full Text] [Related]  

  • 33. A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan.
    Kanno T; Iijima K; Abe Y; Yagi M; Asonuma S; Ohyauchi M; Ito H; Koike T; Shimosegawa T
    J Gastroenterol Hepatol; 2015 May; 30(5):842-8. PubMed ID: 25532720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Helicobacter pylori infection in peptic ulcer disease].
    Takeda H; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():13-8. PubMed ID: 11979764
    [No Abstract]   [Full Text] [Related]  

  • 35. Helicobacter pylori and non-malignant diseases.
    Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
    Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
    Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M
    Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori and peptic-ulcer disease.
    Caselli M; Alvisi V
    Lancet; 2002 Jun; 359(9321):1943-4; author reply 1944. PubMed ID: 12057573
    [No Abstract]   [Full Text] [Related]  

  • 38. Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.
    Taha AS; Russell RI
    Gut; 1993 May; 34(5):580-3. PubMed ID: 8504954
    [No Abstract]   [Full Text] [Related]  

  • 39. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress?
    Aoyama N; Shinoda Y; Matsushima Y; Shirasaka D; Kinoshita Y; Kasuga M; Chiba T
    J Gastroenterol; 2000; 35 Suppl 12():33-7. PubMed ID: 10779215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of H. pylori eradicated patients during more-than-5-year follow-up].
    Kato M; Shimizu Y; Nakagawa S; Kodaira J; Takei M; Furukawa S; Yamamoto F; Takano M; Nagasako T; Nakaya H; Kato T; Oda H; Okawara T; Mizushima T; Komatsu Y; Takeda H; Sugiyama T; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():491-6. PubMed ID: 11979834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.